(0.30%) 5 085.54 points
(-0.05%) 38 483 points
(0.79%) 15 820 points
(-0.46%) $82.98
(-3.20%) $1.754
(-0.36%) $2 333.70
(-0.32%) $27.28
(-0.78%) $915.60
(0.07%) $0.935
(0.62%) $10.97
(0.01%) $0.803
(-0.79%) $92.45
-2.04% ¥ 2 922.00
Live Chart Being Loaded With Signals
Rohto Pharmaceutical Co.,Ltd. manufactures and markets pharmaceutical products, cosmetics, and functional foods worldwide. The company provides eye care products, such as eye drops, care for contact lenses, and eye wash; and facial care products comprising face wash, lotions, and creams...
Stats | |
---|---|
Today's Volume | 927 100 |
Average Volume | 849 759 |
Market Cap | 666.62B |
EPS | ¥0 ( 2024-02-09 ) |
Next earnings date | ( ¥0 ) 2024-05-10 |
Last Dividend | ¥12.00 ( 2023-03-30 ) |
Next Dividend | ¥0 ( N/A ) |
P/E | 21.58 |
ATR14 | ¥1.572 (0.05%) |
Volume Correlation
Rohto Pharmaceutical Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Rohto Pharmaceutical Correlation - Currency/Commodity
Rohto Pharmaceutical Financials
Annual | 2022 |
Revenue: | ¥238.66B |
Gross Profit: | ¥137.42B (57.58 %) |
EPS: | ¥115.62 |
Q3 | 2023 |
Revenue: | ¥73.29B |
Gross Profit: | ¥43.36B (59.16 %) |
EPS: | ¥41.92 |
Q2 | 2023 |
Revenue: | ¥66.70B |
Gross Profit: | ¥38.19B (57.26 %) |
EPS: | ¥32.89 |
Q1 | 2023 |
Revenue: | ¥61.17B |
Gross Profit: | ¥35.77B (58.48 %) |
EPS: | ¥39.84 |
Financial Reports:
No articles found.
Rohto Pharmaceutical Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
¥10.00 (N/A) |
¥0 (N/A) |
¥12.00 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | ¥3.75 | 2001-03-27 |
Last Dividend | ¥12.00 | 2023-03-30 |
Next Dividend | ¥0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 46 | -- |
Total Paid Out | ¥208.50 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.98 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 5.70 | |
Div. Directional Score | 8.41 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
9896.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
8934.T | Ex Dividend Junior | 2023-09-28 | Annually | 0 | 0.00% | |
8029.T | Ex Dividend Junior | 2023-12-28 | Annually | 0 | 0.00% | |
7277.T | Ex Dividend Junior | 2023-09-28 | Annually | 0 | 0.00% | |
6513.T | Ex Dividend Junior | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
5741.T | Ex Dividend Junior | 2023-09-28 | Annually | 0 | 0.00% | |
4539.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
3762.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
3030.T | Ex Dividend Junior | 2024-02-28 | Sporadic | 0 | 0.00% | |
1909.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.117 | 1.500 | 7.66 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0903 | 1.200 | 6.99 | 8.39 | [0 - 0.3] |
returnOnEquityTTM | 0.137 | 1.500 | 9.59 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 2.56 | 0.800 | 2.19 | 1.755 | [1 - 3] |
quickRatioTTM | 1.852 | 0.800 | 3.81 | 3.05 | [0.8 - 2.5] |
cashRatioTTM | 0.979 | 1.500 | 5.67 | 8.51 | [0.2 - 2] |
debtRatioTTM | 0.0282 | -1.500 | 9.53 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 174.35 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 74.69 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 74.69 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.0401 | -1.500 | 9.84 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.582 | 1.000 | 3.64 | 3.64 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.154 | 1.000 | 8.92 | 8.92 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 1.769 | 1.000 | 1.283 | 1.283 | [0.2 - 2] |
assetTurnoverTTM | 0.770 | 0.800 | 8.20 | 6.56 | [0.5 - 2] |
Total Score | 11.11 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 21.58 | 1.000 | 7.92 | 0 | [1 - 100] |
returnOnEquityTTM | 0.137 | 2.50 | 9.74 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 74.69 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0.924 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 74.69 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.824 | 1.500 | 7.84 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0647 | 1.000 | -0.884 | 0 | [0.1 - 0.5] |
Total Score | 5.70 |
Rohto Pharmaceutical
Rohto Pharmaceutical Co.,Ltd. manufactures and markets pharmaceutical products, cosmetics, and functional foods worldwide. The company provides eye care products, such as eye drops, care for contact lenses, and eye wash; and facial care products comprising face wash, lotions, and creams. It also offers medicine and medicated products for skin; medicine for internal use, such as digestive and herbal medicines; oral medicines comprising gastrointestinal medicines, herbal medicines, and supplements; non-prescription medicines; and beauty counters that provide beauty and health services. The company was formerly known as Yamada Pharmaceutical and changed its name to Rohto Pharmaceutical Co.,Ltd. in September 1949. Rohto Pharmaceutical Co.,Ltd. was founded in 1899 and is headquartered in Osaka, Japan.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators